• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国放射学会适宜性标准®子宫内膜癌的预处理评估与随访

ACR Appropriateness Criteria® Pretreatment Evaluation and Follow-Up of Endometrial Cancer.

作者信息

Reinhold Caroline, Ueno Yoshiko, Akin Esma A, Bhosale Priyadarshani R, Dudiak Kika M, Jhingran Anuja, Kang Stella K, Kilcoyne Aoife, Lakhman Yulia, Nicola Refky, Pandharipande Pari V, Paspulati Rajmohan, Shinagare Atul B, Small William, Vargas Hebert Alberto, Whitcomb Bradford P, Glanc Phyllis

机构信息

Panel Chair, McGill University, Montreal, Quebec, Canada.

Research Author, Kobe University Graduate School of Medicine, Kobe, Japan, McGill University, Montreal, Quebec, Canada.

出版信息

J Am Coll Radiol. 2020 Nov;17(11S):S472-S486. doi: 10.1016/j.jacr.2020.09.001.

DOI:10.1016/j.jacr.2020.09.001
PMID:33153558
Abstract

To date, there is little consensus on the role of pelvic imaging in assessing local disease extent during initial staging in patients with endometrial carcinoma, with practices differing widely across centers. However, when pretreatment assessment of local tumor extent is indicated, MRI is the preferred imaging modality. Preoperative imaging of endometrial carcinoma can define the extent of disease and indicate the need for subspecialist referral in the presence of deep myometrial invasion, cervical extension, or suspected lymphadenopathy. If distant metastatic disease is clinically suspected, preoperative assessment with cross-sectional imaging or PET/CT may be performed. However, most patients with low-grade disease are at low risk of lymph node and distant metastases. Thus, this group may not require a routine pretreatment evaluation for distant metastases. Recurrence rates in patients with endometrial carcinoma are infrequent. Therefore, radiologic evaluation is typically used only to investigate suspicion of recurrent disease due to symptoms or physical examination and not for routine surveillance after treatment. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.

摘要

迄今为止,对于盆腔成像在评估子宫内膜癌患者初始分期时局部疾病范围的作用,几乎没有达成共识,各中心的做法差异很大。然而,当需要对局部肿瘤范围进行预处理评估时,MRI是首选的成像方式。子宫内膜癌的术前成像可以确定疾病范围,并在存在肌层深部浸润、宫颈受累或疑似淋巴结病的情况下表明需要转诊至专科医生处。如果临床上怀疑有远处转移性疾病,可进行术前横断面成像或PET/CT评估。然而,大多数低级别疾病患者发生淋巴结转移和远处转移的风险较低。因此,这组患者可能不需要常规的远处转移预处理评估。子宫内膜癌患者的复发率较低。因此,放射学评估通常仅用于因症状或体格检查怀疑复发疾病的调查,而不是用于治疗后的常规监测。美国放射学会适宜性标准是针对特定临床情况的循证指南,每年由多学科专家小组进行审查。指南的制定和修订包括对同行评审期刊上的当前医学文献进行广泛分析,以及应用成熟的方法(兰德/加州大学洛杉矶分校适宜性方法和推荐评估、制定和评价分级或GRADE)来评估特定临床场景下成像和治疗程序的适宜性。在缺乏证据或证据不明确的情况下,专家意见可能会补充现有证据以推荐成像或治疗。

相似文献

1
ACR Appropriateness Criteria® Pretreatment Evaluation and Follow-Up of Endometrial Cancer.美国放射学会适宜性标准®子宫内膜癌的预处理评估与随访
J Am Coll Radiol. 2020 Nov;17(11S):S472-S486. doi: 10.1016/j.jacr.2020.09.001.
2
ACR Appropriateness Criteria® Staging and Follow-up of Primary Vaginal Cancer.ACR 适宜性标准® 原发性阴道癌的分期和随访。
J Am Coll Radiol. 2021 Nov;18(11S):S442-S455. doi: 10.1016/j.jacr.2021.08.011.
3
ACR Appropriateness Criteria® Pretreatment Detection, Surveillance, and Staging of Prostate Cancer: 2022 Update.ACR 适宜性标准®:前列腺癌的治疗前检测、监测和分期:2022 年更新版。
J Am Coll Radiol. 2023 May;20(5S):S187-S210. doi: 10.1016/j.jacr.2023.02.010.
4
ACR Appropriateness Criteria Pretreatment Staging of Colorectal Cancer.ACR 适宜性标准:结直肠癌治疗前分期。
J Am Coll Radiol. 2017 May;14(5S):S234-S244. doi: 10.1016/j.jacr.2017.02.012.
5
ACR Appropriateness Criteria® Staging and Post-Therapy Assessment of Head and Neck Cancer.ACR 适宜性标准®头颈部癌症的分期和治疗后评估。
J Am Coll Radiol. 2023 Nov;20(11S):S521-S564. doi: 10.1016/j.jacr.2023.08.008.
6
ACR Appropriateness Criteria Stage I Breast Cancer: Initial Workup and Surveillance for Local Recurrence and Distant Metastases in Asymptomatic Women.ACR 适宜性标准 Ⅰ期乳腺癌:无症状女性局部复发和远处转移的初始检查和监测。
J Am Coll Radiol. 2017 May;14(5S):S282-S292. doi: 10.1016/j.jacr.2017.02.009.
7
ACR Appropriateness Criteria Staging and Follow-Up of Ovarian Cancer.ACR 适宜性标准:卵巢癌的分期和随访。
J Am Coll Radiol. 2018 May;15(5S):S198-S207. doi: 10.1016/j.jacr.2018.03.015.
8
ACR Appropriateness Criteria® Staging and Follow-up of Vulvar Cancer.ACR 适宜性标准®外阴癌分期和随访。
J Am Coll Radiol. 2021 May;18(5S):S212-S228. doi: 10.1016/j.jacr.2021.02.016.
9
ACR Appropriateness Criteria Pretreatment Staging of Muscle-Invasive Bladder Cancer.ACR 适宜性标准——肌肉浸润性膀胱癌的术前分期。
J Am Coll Radiol. 2018 May;15(5S):S150-S159. doi: 10.1016/j.jacr.2018.03.020.
10
ACR Appropriateness Criteria® Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Cancer.ACR 适宜性标准® 局限性肾细胞癌治疗后随访和主动监测。
J Am Coll Radiol. 2019 Nov;16(11S):S399-S416. doi: 10.1016/j.jacr.2019.05.022.

引用本文的文献

1
Predicting aggressive disease and poor outcome in endometrial cancer using preoperative [F]FDG PET primary tumor radiomics.利用术前[F]FDG PET原发性肿瘤影像组学预测子宫内膜癌的侵袭性疾病和不良预后。
Eur J Nucl Med Mol Imaging. 2025 Jun 11. doi: 10.1007/s00259-025-07335-7.
2
Mismatch Repair-Deficient FIGO Stage IA Endometrial Adenocarcinoma With Negative Nodal Biopsy Presenting as Isolated Orbital Metastasis.错配修复缺陷的国际妇产科联盟(FIGO)IA期子宫内膜腺癌,淋巴结活检阴性,表现为孤立性眼眶转移。
Cureus. 2025 Apr 29;17(4):e83216. doi: 10.7759/cureus.83216. eCollection 2025 Apr.
3
Abdominal fat distribution in endometrial cancer: from diagnosis to follow-up.
子宫内膜癌中的腹部脂肪分布:从诊断到随访
BMC Cancer. 2025 May 15;25(1):879. doi: 10.1186/s12885-025-14155-3.
4
Optimizing Final Pathology Determination in Endometrial Cancer: The Role of PET/CT, MRI, and Biopsy in Serous, Mixed Cell, Clear Cell, and Grade 3 Endometrioid Subtypes.优化子宫内膜癌的最终病理诊断:PET/CT、MRI和活检在浆液性、混合细胞型、透明细胞型及3级子宫内膜样亚型中的作用
Diagnostics (Basel). 2025 Mar 14;15(6):731. doi: 10.3390/diagnostics15060731.
5
Environmental sustainability in gynecologic oncology.妇科肿瘤学中的环境可持续性
Gynecol Oncol Rep. 2024 Sep 10;55:101499. doi: 10.1016/j.gore.2024.101499. eCollection 2024 Oct.
6
Endometrial Cancer: 2023 Revised FIGO Staging System and the Role of Imaging.子宫内膜癌:2023年修订的国际妇产科联盟(FIGO)分期系统及影像学的作用
Cancers (Basel). 2024 May 14;16(10):1869. doi: 10.3390/cancers16101869.
7
Application of PET/MRI in Gynecologic Malignancies.PET/MRI在妇科恶性肿瘤中的应用。
Cancers (Basel). 2024 Apr 12;16(8):1478. doi: 10.3390/cancers16081478.
8
Gender bias in shared decision-making among cancer care guidelines: A systematic review.癌症护理指南中共享决策制定的性别偏见:系统评价。
Health Expect. 2023 Jun;26(3):1019-1038. doi: 10.1111/hex.13753. Epub 2023 Apr 5.
9
Magnetic resonance-based radiomics nomogram for predicting microsatellite instability status in endometrial cancer.基于磁共振成像的影像组学列线图预测子宫内膜癌微卫星不稳定性状态
Quant Imaging Med Surg. 2023 Jan 1;13(1):108-120. doi: 10.21037/qims-22-255. Epub 2022 Oct 19.
10
Application of MRI and CT Images in Surgical Treatment of Early Cervical Cancer.MRI 和 CT 图像在早期宫颈癌手术治疗中的应用。
Scanning. 2022 Aug 2;2022:1592449. doi: 10.1155/2022/1592449. eCollection 2022.